Facile Impedimetric Analysis of Neuronal Exosome Markers in Parkinson's Disease Diagnostics.
Anal Chem. 2020 10 20; 92(20):13647-13651.AC

Abstract

The egress of α-synuclein in neuronally derived exosomes predates the clinical presentation of Parkinson's disease (PD), offering a means of developing a predictive or prognostic test. Here, we report the reagentless impedimetric assay of two internal exosome markers (α-synuclein and syntenin-1) from neuronal exosomes. Exosomes were efficiently extracted from patient sera using anti-L1CAM conjugated zwitterionic polymer-modified magnetic beads prior to lysis and analyzed by electrochemical impedance spectroscopy. The quantification of α-synuclein level across 40 clinical samples resolved statistically significant differences between PD patients and healthy controls (HC).

Links

Publisher Full Text
ncbi.nlm.nih.gov
doi.org
dx.doi.org
PMC Free PDF

Authors+Show Affiliations

Fu Y
Department of Chemistry, University of Oxford, Oxford OX1 3QZ, United Kingdom.
Jiang C
Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
Tofaris GK
Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
Davis JJ
Department of Chemistry, University of Oxford, Oxford OX1 3QZ, United Kingdom.

MeSH

Antibodies, ImmobilizedBiomarkersDielectric SpectroscopyExosomesHumansLimit of DetectionMagneticsNeural Cell Adhesion Molecule L1Parkinson DiseasePolymersSynteninsalpha-Synuclein

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32945162